+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Intermediate Uveitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • PDF Icon

    Report

  • 72 Pages
  • April 2019
  • Region: Global
  • VPA Research
  • ID: 4767752
The global clinical trial report- “2019 Intermediate Uveitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Intermediate Uveitis. It presents in-depth analysis of Intermediate Uveitis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Intermediate Uveitis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Intermediate Uveitis clinical trials by:
  • Current Trial Status

  • Type of the trial

  • Sponsor Type

  • Enrollment Trends

  • Region

  • Countries

  • Trial Phase



The report also identifies the potential drug candidates under development for treatment of Intermediate Uveitis

The research work is prepared through extensive and continuous research on Intermediate Uveitis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.

  • Drug candidates currently being researched for administering Intermediate Uveitis patients are identified

  • The report includes panorama of Intermediate Uveitis clinical trials across the globe

  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided

  • Companies and universities focusing on Intermediate Uveitis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)

  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included

  • Both interventional and observational studies are analyzed

  • News and latest developments for the past one year are presented in the report

Table of Contents

1.1 List of Figures1.2 List of Tables
2. Executive Summary
2.1 Intermediate Uveitis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Intermediate Uveitis Clinical Trials by Region
2.2.2 Average Enrollment of Intermediate Uveitis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Intermediate Uveitis Treatment, 2019
3. Region wise Intermediate Uveitis Clinical Trials
3.1 Asia Pacific Intermediate Uveitis Clinical Trials by Country
3.2 Europe Intermediate Uveitis Clinical Trials by Country
3.3 North America Intermediate Uveitis Clinical Trials by Country
3.4 Middle East and Africa Intermediate Uveitis Clinical Trials by Country
3.5 South and Central America Intermediate Uveitis Clinical Trials by Country
4. Intermediate Uveitis Clinical Trial Trends
4.1 Start Year wise Intermediate Uveitis Clinical Trials
4.2 Phase wise Intermediate Uveitis Clinical Trials
4.3 Trial Status wise Intermediate Uveitis Clinical Trials
4.4 Trial Type wise Intermediate Uveitis Clinical Trials
5. Intermediate Uveitis Average Enrollment Trends
5.1 Average Enrollment in Intermediate Uveitis Trials by Year
5.2 Average Enrollment in Intermediate Uveitis Trials by Phase
5.3 Average Enrollment in Intermediate Uveitis Trials by Status
5.4 Average Enrollment in Intermediate Uveitis Trials by Type of Trial
6. Companies Participating in Intermediate Uveitis Clinical Trials
6.1 Intermediate Uveitis Trials by Sponsor Type
6.2 Intermediate Uveitis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Intermediate Uveitis Trials- Phase 1
7.2 Intermediate Uveitis Trials- Phase 2
7.3 Intermediate Uveitis Trials- Phase 3
7.4 Intermediate Uveitis Trials- Phase 4
8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
List of Figures
Figure 1: Intermediate Uveitis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Intermediate Uveitis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Intermediate Uveitis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Intermediate Uveitis Clinical Trials and Enrolment
Figure 7: North America - Country wise Intermediate Uveitis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Intermediate Uveitis Clinical Trials and Enrolment
Figure 9: Intermediate Uveitis Clinical Trials by Phase
Figure 10: Intermediate Uveitis Clinical Trials by Trial Status
Figure 11: Intermediate Uveitis Clinical Trials by Type
Figure 12: Intermediate Uveitis Clinical Trials by Sponsor Type
Figure 13: Intermediate Uveitis Clinical Trials by Leading Sponsors
Figure 14: Intermediate Uveitis Average Enrollment by Phase
Figure 15: Intermediate Uveitis Average Enrollment by Trial Status
Figure 16: Intermediate Uveitis Average Enrollment by Type
Figure 17: Intermediate Uveitis- Average Enrolment by Type of Sponsors
Figure 18: Intermediate Uveitis- Enrolment by Leading Sponsors
Figure 19: Research Methodology
List of Tables
Table 1: Intermediate Uveitis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Intermediate Uveitis Clinical Trials and Enrolment
Table 5: Europe - Country wise Intermediate Uveitis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Intermediate Uveitis Clinical Trials and Enrolment
Table 7: North America - Country wise Intermediate Uveitis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Intermediate Uveitis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Intermediate Uveitis Average Enrollment by Phase
Table 15: Intermediate Uveitis Average Enrollment by Trial Status
Table 16: Intermediate Uveitis Average Enrollment by Type
Table 17: Intermediate Uveitis- Average Enrolment by Type of Sponsors
Table 18: Intermediate Uveitis- Enrolment by Leading Sponsors

Companies Mentioned

  • Abbott Laboratories

  • AbbVie Inc

  • Accutest Research Laboratories India Pvt Ltd

  • Clearside BioMedical Inc

  • Les Laboratoires Servier SAS

  • Lux Biosciences Inc

  • MallInckrodt Plc

  • Novartis AG

  • pSivida Corp

  • XOMA Corp